4.8 • 7.2K Ratings
🗓️ 26 February 2025
⏱️ 80 minutes
🧾️ Download transcript
Over the last several years, GLP-1 agonist medications have gained traction as an effective way for folks to lose weight and improve their metabolic health. GLP-1 medications have proven to result in weight loss, but after discontinuing the drug, weight regain is common. Today, you’re going to learn the full story behind GLP-1, foods that increase your natural GLP-1 activity, and so much more.
On this episode of The Model Health Show, I’m sitting down with Dr. Tasneem Bhatia. Dr. Taz is a double board-certified integrative medicine physician, best-selling author, and a pioneer of merging holistic medicine with conventional medicine. In this conversation, she’s sharing what goes on behind the scenes with metabolic health and GLP-1.
This episode is a goldmine of information, including what you should be eating for optimal health, the role of blood sugar and gut health in regulating metabolism, and how to create a strategic approach that allows your body to heal. Dr. Taz is also sharing her clinical experience with prescribing GLP-1 microdosing to her patients, the benefits, and how this approach differs from the conventional dosing schedule. I hope you enjoy this interview with the one and only, Dr. Taz!
In this episode you’ll discover:
Items mentioned in this episode include:
Be sure you are subscribed to this podcast to automatically receive your episodes:
This episode of The Model Health Show is brought to you by Foursigmatic and LMNT.
Visit foursigmatic.com/model to get an exclusive 10% discount on mushroom and adaptogen-packed blends to improve your life.
Head to DrinkLMNT.com/model to claim a FREE sample pack of electrolytes with any purchase.
Click on a timestamp to play from that location
0:00.0 | You are now listening to The Model Health Show with Sean Stevenson. |
0:04.7 | For more, visit the modelhealth show.com. |
0:11.7 | Welcome to the model health show. |
0:13.4 | This is fitness and nutrition expert, Sean Stevenson, and I'm so grateful for you tuning in with me today. |
0:18.9 | GLP1, GLP1, GLP one drugs have hit our society |
0:26.0 | harder than just about anything we've ever seen. |
0:30.1 | Harder than K-pop, harder than any boy band you can name. |
0:35.1 | They're out here heavy. |
0:36.6 | And the question is, what is the cost? And I'm not talking |
0:40.3 | about economically to buy the drugs. I'm talking about what is the cost for our health? What is the |
0:46.0 | cost for our society? And will this work long term? Well, the longest running study looking at the benefits and the potential downsides of the |
0:59.7 | semaglutide camp of drugs the glp1 drugs so we're talking about wagovi we're talking about |
1:06.6 | ozimic and the like this study was published in the journal diabetes obesity and metabolism and it was |
1:14.8 | titled weight regain and cardiometabolic effects after withdrawal after withdrawal of |
1:23.5 | samaglutide now this was a randomized trial conducted over a year |
1:28.9 | looking at the weight loss and the metabolic effects |
1:31.9 | of utilizing this class of drugs. |
1:34.6 | And it worked really well. |
1:36.6 | People lost weight. |
1:38.7 | Their cardiovascular cardiomatabolic numbers improved. |
1:43.4 | But, and here's the big old but that some people lost, |
1:48.0 | in just a short amount of time after discontinuing the use of the drug, participants began to |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Shawn Stevenson, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Shawn Stevenson and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.